4//SEC Filing
BJERKHOLT ERIC 4
Accession 0001415889-25-021522
CIK 0001759425other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 8:00 PM ET
Size
9.1 KB
Accession
0001415889-25-021522
Insider Transaction Report
Form 4
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-08-12−2,954→ 29,046 totalExercise: $26.49Exp: 2034-01-22→ Common Stock (2,954 underlying) - Sale
Common Stock
2025-08-11−8,000→ 28,236 total - Exercise/Conversion
Common Stock
2025-08-12$26.49/sh+2,954$78,251→ 31,190 total
Footnotes (3)
- [F1]The weighted average sale price for the transaction reported was $65.50, and the range of prices were between $65.31 and $66.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F2]Includes 290 shares of Common Stock that were acquired by the Reporting Person on May 10, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]1/4th of the shares vested one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001197350
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 8:00 PM ET
- Size
- 9.1 KB